ALGOMEDIX
ALGOMEDIX is a biotechnology company developing novel therapeutics to treat pain, inflammation, and ocular and dermatological diseases.
ALGOMEDIX
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2010-01-01
Address:
Mill Creek, Pennsylvania, United States
Country:
United States
Website Url:
http://www.algomedix.com
Total Employee:
1+
Status:
Active
Contact:
425.379.7900
Technology used in webpage:
Google Maps Google Akismet Akismet Non Hosted
Similar Organizations
AevisBio
AevisBio is a biotech company that develops therapeutics for neurological and immunological disorders.
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
Alvine Pharmaceuticals
Alvine Pharmaceuticals is a biotechnology company developing therapeutics for autoimmune and inflammatory diseases.
ARNA Therapeutics
ARNA Therapeutics is a biotechnology company developing new therapeutic approaches to treat patients with neuro-degenerative diseases.
Bolden Therapeutics
Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases.
Georgiamune
Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Official Site Inspections
http://www.algomedix.com Semrush global rank: 13.44 M Semrush visits lastest month: 78
- Host name: 191.51.212.35.bc.googleusercontent.com
- IP address: 35.212.51.191
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "ALGOMEDIX"
About Us - Algomedix TRP Therapeutics
Algomedix is a leader in the development of novel Transient Receptor Potential (TRP) therapeutics to treat serious medical needs including chronic and acute pain as well as chronic …See details»
ALGOMEDIX - Crunchbase Company Profile & Funding
ALGOMEDIX is a biotechnology company developing novel therapeutics to treat pain, inflammation, and ocular and dermatological diseases. ... Products. Resources. Pricing. Resources. Log In. Organization. ALGOMEDIX . Connect …See details»
Management - Algomedix TRP Therapeutics
Jeffrey Herz, Ph.D. President and Chief Executive Officer Jeffrey Herz, Ph.D., is the founder of Algomedix and serves as the current Chairman of the Board, President and CEO. He has …See details»
ALGOMEDIX, INC. - LinkedIn
Algomedix is an emerging biotechnology company which is using the advances in precision medicine to accelerate drug discovery and development for TRP (Transient Receptor …See details»
ALGOMEDIX, INC. Overview | SignalHire Company Profile
Algomedix is an emerging biotechnology company focused on the discovery and development of novel therapeutics to treat pain, inflammation, ocular and dermatological disease. ... Show …See details»
Algomedix - VentureRadar
Algomedix is a leader in the development of novel Transient Receptor Potential (TRP) therapeutics to treat serious medical needs including chronic and acute pain as well as chronic …See details»
Algomedix, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Last update 02 May 2024. Algomedix, Inc. Private Company |See details»
ALGOMEDIX - Crunchbase
ALGOMEDIX is a biotechnology company developing novel therapeutics to treat pain, inflammation, and ocular and dermatological diseases.See details»
Algomedix, Inc. Company Profile | Mill Creek, WA | Competitors ...
Find company research, competitor information, contact details & financial data for Algomedix, Inc. of Mill Creek, WA. Get the latest business insights from Dun & Bradstreet.See details»
Algomedix Company Profile - Office Locations, Competitors ... - Craft
Algomedix is a company engaged in the development of Transient Receptor Potential (TRP) therapeutics to treat serious medical needs, including chronic and acute pain. It also provides …See details»
Board of Directors - Algomedix TRP Therapeutics
Dr. Jeffrey Herz, Ph.D. Founder and CEO, Algomedix Jeffrey Herz, Ph.D., is the founder of Algomedix and serves as the current Chairman of the Board, President and CEO. He has …See details»
Algomedix (DRZFLVKY7S13) - HigherGov
Federal grant recipient ALGOMEDIX, INC. (UEI DRZFLVKY7S13, CAGE 623E4) is headquartered in Mill Creek WA. Its primary registered NAICS is 541714 Research and …See details»
Algomedix Company Profile | Management and Employees List
Find contact information for Algomedix. Learn about their Manufacturing market share, competitors, and Algomedix's email format.See details»
Algomedix - Overview, News & Similar companies | ZoomInfo.com
Algomedix is an emerging biopharmaceutical company focused on developing novel therapeutics for the treatment of chronic pain and inflammation. Mor e than 100 million Americans suffer …See details»
Algomedix, Inc.:Company Profile & Technical Research,Competitor …
Algomedix, Inc. is a company that provides Inflammation, Dermatological diseases and more. Algomedix, Inc. is headquartered in United States Pennsylvania. Algomedix, Inc. was founded …See details»
ALGOMEDIX - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. ALGOMEDIX . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 10. Monthly Visits 75. ...See details»
Algomedix | VentureRadar
Algomedix is a leader in the development of novel Transient Receptor Potential (TRP) therapeutics to treat serious medical needs including chronic and acute pain as well as chronic …See details»
Algomedix, Inc. (Algomedix, Inc.) - 药物管线_专利_临床试验_投融 …
Key Players Boehringer Ingelheim Eli Lilly and Company Reata Pharmaceuticals Novo Nordisk KBP Biosciences AstraZeneca Allena Pharmaceuticals SCOHIA PHARMA DiaMedica …See details»
Partnering - Algomedix TRP Therapeutics
Partnering / Partnerships Partnering We are committed to building the next-generation of TRP channel targeted first-in-class medicines. As part of our value-creation strategy, the company …See details»